Hermawan GN, Laihad BJ, Wagey FMM, Mongan SP, Aprilia B. Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis. ijirss [Internet]. 2025 Jun. 24 [cited 2025 Dec. 5];8(4):1223-32. Available from: https://ijirss.com/index.php/ijirss/article/view/8050